WEED, Inc. (BUDZ)
OTCMKTS · Delayed Price · Currency is USD
0.0325
+0.0001 (0.31%)
Aug 25, 2025, 2:52 PM EDT
WEED, Inc. Market Cap
WEED, Inc. has a market cap or net worth of $4.40 million as of August 25, 2025. Its market cap has decreased by -38.61% in one year.
Market Cap
4.40M
Enterprise Value
4.77M
Revenue
n/a
Ranking
n/a
PE Ratio
n/a
Stock Price
$0.03
Market Cap Chart
Since February 3, 2015, WEED, Inc.'s market cap has increased from 2.06M to 4.40M, an increase of 113.70%. That is a compound annual growth rate of 7.46%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Aug 22, 2025 | 4.40M | 9.37% |
| Dec 31, 2024 | 4.03M | -55.33% |
| Dec 29, 2023 | 9.01M | -14.12% |
| Dec 30, 2022 | 10.50M | -66.14% |
| Dec 31, 2021 | 31.00M | 24.28% |
| Dec 31, 2020 | 24.94M | -27.80% |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2016 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2015 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Nika Pharmaceuticals | 972.93M |
| Veradigm | 823.67M |
| Tian'an Technology Group | 682.77M |
| Glass House Brands | 634.05M |
| Elite Pharmaceuticals | 587.83M |
| American Oncology Network | 382.44M |
| CytoDyn | 372.36M |
| Northwest Biotherapeutics | 366.64M |